SCHEMBL7775133

SCHEMBL7775133

NC(Cc1c[nH]c2ccccc12)C(=O)Oc1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.71
MAPT P10636 2/20 0.71
MEN1 O00255 2/20 0.71
KMT2A Q03164 2/20 0.71
LMNA P02545 1/20 0.71
MPO P05164 1/20 0.71
TSHR P16473 1/20 0.71
BLM P54132 1/20 0.71
PMP22 Q01453 1/20 0.71
HIF1A Q16665 1/20 0.71
TACR1 P25103 2/20 0.61
SMN1; SMN2 Q16637 1/20 0.57
APAF1 O14727 1/20 0.56
POLB P06746 1/20 0.56
RECQL P46063 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
SCN9A Q15858 3/20 0.55
FAAH O00519 1/20 0.55
HTR2A P28223 2/20 0.54
ADRB1 P08588 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1401159 1.00 KDM4E (0.71) KDM4EMAPTMEN1KMT2ALMNA
SCHEMBL27582874 0.90 MEN1 (0.61) KDM4EMAPTMEN1KMT2ALMNA
SCHEMBL29233343 0.90 MAPT (0.61) KDM4EMAPTMEN1KMT2ALMNA
SCHEMBL6032937 0.90 KMT2A (0.71) KDM4EMAPTMEN1KMT2ALMNA
SCHEMBL597229 0.90 KMT2A (0.71) KDM4EMAPTMEN1KMT2ALMNA
SCHEMBL1239230 0.89 MEN1 (0.59) KDM4EMAPTMEN1KMT2ALMNA
Phenylalanine SCHEMBL10381280 0.89 KMT2A (0.70) KDM4EMAPTMEN1KMT2ALMNA
Tryptophan SCHEMBL28205631 0.88 KMT2A (0.65) KDM4EMAPTMEN1KMT2ALMNA
SCHEMBL6535365 0.88 MEN1 (0.58) KDM4EMAPTMEN1KMT2ALMNA
SCHEMBL6535879 0.88 MEN1 (0.58) KDM4EMAPTMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11517516-B2 Use of ester derivative of tryptophan as deodorant and/or perfume agent L'OREAL (FR) 2022-12-06 US disclosed
EP-3233798-B1 USE OF ESTER DERIVATIVE OF TRYPTOPHAN AS DEODORANT AND/OR PERFUME AGENT OREAL (FR) 2019-04-10 EP disclosed
US-20170360668-A1 USE OF ESTER DERIVATIVE OF TRYPTOPHAN AS DEODORANT AND/OR PERFUME AGENT L'OREAL (FR) 2017-12-21 US disclosed
US-20170360668-A1 USE OF ESTER DERIVATIVE OF TRYPTOPHAN AS DEODORANT AND/OR PERFUME AGENT L'OREAL (FR) 2017-12-21 US disclosed
WO-2016097398-A1 USE OF ESTER DERIVATIVE OF TRYPTOPHAN AS DEODORANT AND/OR PERFUME AGENT L'OREAL (FR) 2016-06-23 WO disclosed
EP-1135398-A1 CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION Monsanto Technology LLC (US) 2001-09-26 EP disclosed
US-6218563-B1 Cyanophosphonamides and method for preparation MONSANTO COMPANY 2001-04-17 US disclosed
WO-2000032611-A1 CYANOPHOSPHONAMIDES AND METHOD FOR PREPARATION MONSANTO TECHNOLOGY LLC (US) 2000-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11517516-B2 Use of ester derivative of tryptophan as deodorant and/or perfume agent TPH1, TPH2, TDO2 KDM4E 2708/4885MAPT 1207/4885MEN1 4192/4885
US-20170360668-A1 USE OF ESTER DERIVATIVE OF TRYPTOPHAN AS DEODORANT AND/OR PERFUME AGENT TPH1, TPH2, TDO2 KDM4E 1957/4885MAPT 1773/4885MEN1 4447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.